32 Nova´k et al.
5-1A.∗ 31P NMR (CDCl3) δ: 37.8; 13C NMR (CDCl3)
δ: 22.5 (J = 8.5, CH3), 29.8 (J = 63.2, C6),a 33.1
1H, J1 = 18.1, J2 = 8.3, J3 = 2.2, CH2), 1.23 (ddd, 1H,
J1 = 16.0, J2 = 7.6, J3 = 2.0, CH2), 2.29–2.43 (m, 2H,
CH2 and CH), 2.65–2.75 (m, 1H, CH2), 3.36 (dt, 2H,
J = 28.8, 13.5, CH2Ph), 7.22–7.40 (m, 5H, Ar).
3B. 31P NMR (CDCl3) δ: 88.6.
(J = 59.5, C2),a 36.4 (J = 63.0, CPh),b 55.8 (CH3O),
c
ꢁ
78.5 (J = 4.2, C3), 126.7 (C4 ), 128.6 (J = 5.3, C5),
d
e
ꢁ
ꢁ
128.4 (C3 ), 129.0 (J = 5.1, C2 ), 130.6 (J = 11.1,
f
1
ꢁ
C1 ), 137.3 (J = 11.4, C4); H NMR (CDCl3) δ: 1.88
(s, 3H, CH3), 2.00–2.72 (m, 4H, P(CH2)2), 3.21 (d,
2H, J = 15.0, CH2Ph), 3.43 (s, 3H, OCH3),g 4.00–4.30
(m, 1H, CH), 7.10–7.42 (m, 5H, Ar).
1-Benzyl-4-chloro-3-methyl-1,2-dihydrophosphi-
nine 1-oxide 4
5-2A. 31P NMR (CDCl3) δ: 35.0; 13C NMR (CDCl3)
δ: 22.9 (J = 8.5, CH3), 28.9 (J = 62.5, C6),h 31.3
(J = 62.0, C2),h 37.5 (J = 62.8, CPh),b 57.3 (CH3O),
A 0.50 g (1.73 mmol) sample of phosphabicyclo-
hexane oxide 2 consisting of isomers A (75%) and
B (25%) was heated at 135◦C in a vial for 4 min
(the evolution of hydrochloride acid started after
1 min). The crude product was purified by column
chromatography (2% methanol in chloroform, sil-
ica gel) to give 0.38 g (87%) of dihydrophosphi-
nine 1-oxide 4 as a 3:1 mixture of 4A and 4B. MS,
253 (100, [M + H]+), 154 (68), 136 (67), 91 (93), 69
(82); HRMS, [M + H]+found = 253.0555, C13H15ClOP re-
quires 253.0549.
c
d
ꢁ
ꢁ
79.1 (J = 5.3, C3), 126.7 (C4 ), 128.4 (C3 ), 129.4
e
f
ꢁ
ꢁ
(J = 5.1, C2 ), 131.0 (J = 8.5, C1 ), 137.5 (J = 9.6, C4);
1H NMR (CDCl3) δ: 1.94 (s, 3H, CH3), 2.00–2.72 (m,
4H, P(CH2)2), 3.21 (d, 2H, J = 15.0, CH2Ph), 3.37 (s,
3H, OCH3),g 4.00–4.30 (m, 1H, CH), 7.10–7.42 (m,
5H, Ar).
5-3B. 31P NMR (CDCl3) δ: 35.8; 13C NMR (CDCl3)
δ: 25.8 (J = 63.5, C6), 26.9 (J = 5.6, CH3), 35.7
4A. 31P NMR (CDCl3) δ: 23.9; 13C NMR (CDCl3) δ:
22.2 (J = 8.4, CH3), 31.6 (J = 69.3,C2), 37.0 (J = 68.1,
C7), 118.0 (J = 89.9, C6), 122.7 (J = 18.8, C3), 126.0
(J = 60.7, C2), 36.4 (J = 63.5, CPh),b 50.4 (CH3O),
c
ꢁ
77.0 (J = 3.1, C3), 122.4 (J = 6.2, C5), 126.7 (C4 ),
d
e
ꢁ
ꢁ
127.9 (J = 10.9, C4), 128.4 (C3 ), 129.1 (J = 4.9, C2 ),
130.7 (J = 8.1, C1 ) ; 1H NMR (CDCl3) δ: 1.52 (s,
3H, CH3), 2.00–2.72 (m, 4H, P(CH2)2), 3.21 (d, 2H,
J = 15.0, CH2Ph), 3.22 (s, 3H, OCH3),g 6.06 (bdt, 1H,
J1 = 23.0, J2 = 10.0, CH ), 7.10–7.42 (m, 5H, Ar).
5-4B. 31P NMR (CDCl3) δ: 36.1; 13C NMR (CDCl3)
δ: 25.5 (J = 2.8, CH3), 26.1 (J = 64.2, C6), 31.7
(J = 63.4, C2), 37.8 (J = 63.7, CPh),b 49.9 (CH3O),
76.7 (J = 3.1, C3), 121.5 (J = 7.0, C5), 126.5 (J = 2.0,
f
ꢁ
ꢁ
(J = 3.3, C4), 126.1 (J = 3.3, C4 ), 127.8 (J = 2.8, C3 ),
ꢁ
ꢁ
ꢁ
128.6 (J = 5.3, C2 ), 130.0 (J = 7.9, C1 ), 142.4 (J = 1.2,
1
C5); H NMR (CDCl3) δ: 1.96 (s, 3H, CH3), 2.58 (dd,
1H, J = 18.6, 11.3, CH2), 2.76 (t, 1H, J = 19.5, CH2),
3.26 (dd, 2H, J = 15.5, 4.2, CH2Ph), 6.08 (t, 1H,
J = 12.7, C6H), 6.67 (dd, 1H, J = 34.1, 12.9, C5H),
7.22–7.38 (m, 5H, Ar).
4B. 31P NMR (CDCl3) δ: 22.5; 13C NMR (CDCl3)
δ: 23.6 (J = 12.5, CH3), 30.2 (J = 68.0, C2), 36.6
(J = 68.4, CPh), 117.5 (J = 93.6, C6), 122.2 (J = 10.2,
c
d
ꢁ
ꢁ
C4 ), 127.4 (J = 11.4, C4), 128.2 (C3 ), 129.1 (J = 5.0,
e
f 1
ꢁ
ꢁ
C2 ), 130.7 (J = 7.5, C1 ) ; H NMR (CDCl3) δ: 1.59 (s,
3H, CH3), 2.00–2.72 (m, 4H, P(CH2)2), 3.21 (d, 2H, J
= 15.0, CH2Ph), 3.16 (s, 3H, OCH3),g 6.06 (bdt, 1H,
J1 = 23.0, J2 = 10.0, CH), 7.10–7.42 (m, 5H, Ar).
ꢁ
C3), 125.8 (J = 3.1, C4), 126.1 (J = 3.3, C4 ), 127.8
ꢁ
ꢁ
ꢁ
(J = 2.8, C3 ), 128.7 (J = 5.3, C2 ), 130.2 (J = 8.0, C1 ),
1
143.7 (J = 1.6, C5); H NMR (CDCl3) δ: 2.12 (s, 3H,
CH3).
5- and 3-Methyl-1-benzyl-4-chloro-3-hydroxy-
1,2,3,6-tetrahydrophosphinine 1-Oxide 6
5- and 3-Methyl-1-benzyl-4-chloro-3-methoxy-
1,2,3,6-tetrahydrophosphinine 1-oxide 5
A solution of 0.40 g (1.38 mmol) of phosphabicyclo-
hexane oxide 2 consisting of isomers A (75%) and
B (25%) and 2.4 g (13.8 mmol) of silver nitrate in
10 mL of water was refluxed for 2 h. After filtration,
the mixture was extracted with chloroform and the
organic phase was dried over sodium sulfate and
concentrated. The crude product was purified by
column chromatography (3% methanol in chloro-
form, silica gel) to give 0.22 g (60%) of compound
6 as a 5.5:2.4:1.4:1 mixture of four isomers. MS,
271 (100, [M + H]+), 253 (82), 154 (91), 136 (90), 91
A solution of 0.40 g (1.38 mmol) of phosphabicyclo-
hexane oxide 2 consisting of isomers A (75%) and
B (25%) and 4.2 g (25.0 mmol) of silver nitrate in
15 mL of methanol was refluxed for 24 h. After filtra-
tion, the mixture was extracted with chloroform and
the organic phase was dried over sodium sulfate and
concentrated. The crude product was purified by col-
umn chromatography (3% methanol in chloroform,
silica gel) to give 0.29 g (70%) of compound 5 as a
40:28:21:10 mixture of four isomers with a purity of
95%. A further refinement by chromatography led
to a 1:1.1:1.2:1 mixture of the isomers. MS, 285 (88,
[M + H]+), 253 (64), 137 (100); HRMS, [M + H]+found
= 285.0799, C14H19ClO2P requires 285.0811.
∗ A,Bthe corresponding signals within the isomer pairs may be re-
versed. a−htentative assignment.
Heteroatom Chemistry DOI 10.1002/hc